36
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      The transcription factor Gli3 promotes B cell development in fetal liver through repression of Shh

      research-article

      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Solanki et al. show that stromal activity of the transcription factor Gli3 is required for B cell development in the fetal liver. Gli3 functions to repress Shh expression, and Shh signals to developing B cells to regulate their development at multiple developmental stages.

          Abstract

          Before birth, B cells develop in the fetal liver (FL). In this study, we show that Gli3 activity in the FL stroma is required for B cell development. In the Gli3-deficient FL, B cell development was reduced at multiple stages, whereas the Sonic hedgehog (Hh [Shh])–deficient FL showed increased B cell development, and Gli3 functioned to repress Shh transcription. Use of a transgenic Hh-reporter mouse showed that Shh signals directly to developing B cells and that Hh pathway activation was increased in developing B cells from Gli3-deficient FLs. RNA sequencing confirmed that Hh-mediated transcription is increased in B-lineage cells from Gli3-deficient FL and showed that these cells expressed reduced levels of B-lineage transcription factors and B cell receptor (BCR)/pre-BCR–signaling genes. Expression of the master regulators of B cell development Ebf1 and Pax5 was reduced in developing B cells from Gli3-deficient FL but increased in Shh-deficient FL, and in vitro Shh treatment or neutralization reduced or increased their expression, respectively.

          Related collections

          Most cited references44

          • Record: found
          • Abstract: found
          • Article: not found

          Transgenic mice with hematopoietic and lymphoid specific expression of Cre.

          Bacteriophage P1 Cre/loxP based systems can be used to manipulate the genomes ofmice in vivo and in vitro, allowing the generation of tissue-specific conditional mutants. We have generated mouse lines expressing Cre recombinase in hematopoietic tissues using the vav regulatory elements, or in lymphoid cells using the hCD2 promoter and locus control region (LCR). The R26R-EYFP Cre reporter mouse line was used to determine the pattern of Cre expression in each line and enabled the assessment of Cre activity at a single-cell level. Analysis showed that the vav promoter elements were able to direct Cre-mediated recombination in all cells of the hematopoietic system. The hCD2 promoter and LCR on the other hand were able to drive Cre-mediated recombination only in T cells and B cells, but not in other hematopoietic cell types. Furthermore, in the appropriate tissues, deletion of the floxed target was complete in all cells, thereby excluding the possibility of variegated expression of the Cre transgene. Both of these Cre-transgenic lines will be useful in generating tissue-specific gene deletions within all the cells of hematopoietic or lymphoid tissues.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            B cell development pathways.

            B cell development is a highly regulated process whereby functional peripheral subsets are produced from hematopoietic stem cells, in the fetal liver before birth and in the bone marrow afterward. Here we review progress in understanding some aspects of this process in the mouse bone marrow, focusing on delineation of the earliest stages of commitment, on pre-B cell receptor selection, and B cell tolerance during the immature-to-mature B cell transition. Then we note some of the distinctions in hematopoiesis and pre-B selection between fetal liver and adult bone marrow, drawing a connection from fetal development to B-1/CD5(+) B cells. Finally, focusing on CD5(+) cells, we consider the forces that influence the generation and maintenance of this distinctive peripheral B cell population, enriched for natural autoreactive specificities that are encoded by particular germline V(H)-V(L) combinations.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Gli2, but not Gli1, is required for initial Shh signaling and ectopic activation of the Shh pathway.

              The Shh signaling pathway is required in many mammalian tissues for embryonic patterning, cell proliferation and differentiation. In addition, inappropriate activation of the pathway has been implicated in many human tumors. Based on transfection assays and gain-of-function studies in frog and mouse, the transcription factor Gli1 has been proposed to be a major mediator of Shh signaling. To address whether this is the case in mouse, we generated a Gli1 null allele expressing lacZ. Strikingly, Gli1 is not required for mouse development or viability. Of relevance, we show that all transcription of Gli1 in the nervous system and limbs is dependent on Shh and, consequently, Gli1 protein is normally not present to transduce initial Shh signaling. To determine whether Gli1 contributes to the defects seen when the Shh pathway is inappropriately activated and Gli1 transcription is induced, Gli1;Ptc double mutants were generated. We show that Gli1 is not required for the ectopic activation of the Shh signaling pathway or to the early embryonic lethal phenotype in Ptc null mutants. Of significance, we found instead that Gli2 is required for mediating some of the inappropriate Shh signaling in Ptc mutants. Our studies demonstrate that, in mammals, Gli1 is not required for Shh signaling and that Gli2 mediates inappropriate activation of the pathway due to loss of the negative regulator Ptc.
                Bookmark

                Author and article information

                Journal
                J Exp Med
                J. Exp. Med
                jem
                jem
                The Journal of Experimental Medicine
                The Rockefeller University Press
                0022-1007
                1540-9538
                03 July 2017
                03 July 2017
                : 214
                : 7
                : 2041-2058
                Affiliations
                [1 ]Great Ormond Street Institute of Child Health, University College London, London, England, UK
                [2 ]School of Health, Sport, and Bioscience, University of East London, London, England, UK
                Author notes
                Correspondence to Tessa Crompton: t.crompton@ 123456ucl.ac.uk
                Author information
                http://orcid.org/0000-0003-3025-4477
                http://orcid.org/0000-0002-8973-4021
                Article
                20160852
                10.1084/jem.20160852
                5502423
                28533268
                dd0e7575-34af-4177-b945-27bdbe363243
                © 2017 Solanki et al.

                This article is available under a Creative Commons License (Attribution 4.0 International, as described at https://creativecommons.org/licenses/by/4.0/).

                History
                : 07 June 2016
                : 28 February 2017
                : 10 April 2017
                Funding
                Funded by: Medical Research Council, DOI http://dx.doi.org/10.13039/501100000265;
                Award ID: G0900161/1
                Award ID: MR/P000843/1
                Funded by: Biotechnology and Biological Sciences Research Council, DOI http://dx.doi.org/10.13039/501100000268;
                Award ID: BB/I026324/1
                Funded by: Wellcome Trust, DOI http://dx.doi.org/10.13039/100004440;
                Award ID: WT094255MF
                Funded by: Great Ormond Street Hospital Children’s Charity, DOI http://dx.doi.org/10.13039/501100001279;
                Funded by: National Institute for Health Research, DOI http://dx.doi.org/10.13039/501100000272;
                Award ID: ormbrc-2012-1
                Funded by: Great Ormond Street Hospital for Children, DOI http://dx.doi.org/10.13039/501100003784;
                Funded by: NHS Foundation Trust
                Funded by: University College London, DOI http://dx.doi.org/10.13039/501100000765;
                Categories
                Research Articles
                Article
                315

                Medicine
                Medicine

                Comments

                Comment on this article